Trial Profile
A study of TK-216 in prostate cancer
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 07 Sep 2017
Price :
$35
*
At a glance
- Drugs ONCT 216 (Primary)
- Indications Prostate cancer
- Focus Adverse reactions
- 07 Sep 2017 New trial record
- 30 Aug 2016 According to an Oncternal Therapeutics, Inc. media release the company has planned this study for next year.